» Articles » PMID: 28240273

Amyloid Plaque Structure and Cell Surface Interactions of β-amyloid Fibrils Revealed by Electron Tomography

Overview
Journal Sci Rep
Specialty Science
Date 2017 Feb 28
PMID 28240273
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

The deposition of amyloid fibrils as plaques is a key feature of several neurodegenerative diseases including in particular Alzheimer's. This disease is characterized, if not provoked, by amyloid aggregates formed from Aβ peptide that deposit inside the brain or are toxic to neuronal cells. We here used scanning transmission electron microscopy (STEM) to determine the fibril network structure and interactions of Aβ fibrils within a cell culture model of Alzheimer's disease. STEM images taken from the formed Aβ amyloid deposits revealed three main types of fibril network structures, termed amorphous meshwork, fibril bundle and amyloid star. All three were infiltrated by different types of lipid inclusions from small-sized exosome-like structures (50-100 nm diameter) to large-sized extracellular vesicles (up to 300 nm). The fibrils also presented strong interactions with the surrounding cells such that fibril bundles extended into tubular invaginations of the plasma membrane. Amyloid formation in the cell model was previously found to have an intracellular origin and we show here that it functionally destroys the integrity of the intracellular membranes as it leads to lysosomal leakage. These data provide a mechanistic link to explain why intracellular fibril formation is toxic to the cell.

Citing Articles

CryoET of β-amyloid and tau within postmortem Alzheimer's disease brain.

Gilbert M, Fatima N, Jenkins J, OSullivan T, Schertel A, Halfon Y Nature. 2024; 631(8022):913-919.

PMID: 38987603 PMC: 11269202. DOI: 10.1038/s41586-024-07680-x.


Imaging Amyloid-β Membrane Interactions: Ion-Channel Pores and Lipid-Bilayer Permeability in Alzheimer's Disease.

Viles J Angew Chem Weinheim Bergstr Ger. 2024; 135(25):e202215785.

PMID: 38515735 PMC: 10952214. DOI: 10.1002/ange.202215785.


Silencing Apoe with divalent-siRNAs improves amyloid burden and activates immune response pathways in Alzheimer's disease.

Ferguson C, Hildebrand S, Godinho B, Buchwald J, Echeverria D, Coles A Alzheimers Dement. 2024; 20(4):2632-2652.

PMID: 38375983 PMC: 11032532. DOI: 10.1002/alz.13703.


Role of mechanoregulation in mast cell-mediated immune inflammation of the smooth muscle in the pathophysiology of esophageal motility disorders.

Goyal R, Rattan S Am J Physiol Gastrointest Liver Physiol. 2024; 326(4):G398-G410.

PMID: 38290993 PMC: 11213482. DOI: 10.1152/ajpgi.00258.2023.


Secondary structure and toxicity of lysozyme fibrils are determined by the length and unsaturation of phosphatidic acid.

Ali A, Zhaliazka K, Holman A, Kurouski D Proteins. 2023; 92(3):411-417.

PMID: 37909765 PMC: 11075103. DOI: 10.1002/prot.26622.


References
1.
Hortschansky P, Schroeckh V, Christopeit T, Zandomeneghi G, Fandrich M . The aggregation kinetics of Alzheimer's beta-amyloid peptide is controlled by stochastic nucleation. Protein Sci. 2005; 14(7):1753-9. PMC: 2253354. DOI: 10.1110/ps.041266605. View

2.
Miyakawa T, Katsuragi S, Watanabe K, Shimoji A, Ikeuchi Y . Ultrastructural studies of amyloid fibrils and senile plaques in human brain. Acta Neuropathol. 1986; 70(3-4):202-8. DOI: 10.1007/BF00686073. View

3.
Terry C, Wenborn A, Gros N, Sells J, Joiner S, Hosszu L . Ex vivo mammalian prions are formed of paired double helical prion protein fibrils. Open Biol. 2016; 6(5). PMC: 4892434. DOI: 10.1098/rsob.160035. View

4.
Schutz A, Vagt T, Huber M, Ovchinnikova O, Cadalbert R, Wall J . Atomic-resolution three-dimensional structure of amyloid β fibrils bearing the Osaka mutation. Angew Chem Int Ed Engl. 2014; 54(1):331-5. PMC: 4502972. DOI: 10.1002/anie.201408598. View

5.
Dinkins M, Dasgupta S, Wang G, Zhu G, Bieberich E . Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease. Neurobiol Aging. 2014; 35(8):1792-800. PMC: 4035236. DOI: 10.1016/j.neurobiolaging.2014.02.012. View